F Franchino, R Rudà, R Soffietti - Frontiers in oncology, 2018 - frontiersin.org
Advances in chemotherapy and targeted therapies have improved survival in cancer patients with an increase of the incidence of newly diagnosed brain metastases (BMs) …
BACKGROUND: Stereotactic radiosurgery (SRS) is an increasingly common modality used with surgery for resectable brain metastases (BM). OBJECTIVE: To present a multi …
MA Franzoi, GN Hortobagyi - Critical reviews in oncology/hematology, 2019 - Elsevier
Leptomeningeal carcinomatosis (LC) is defined as infiltration of the leptomeninges by metastatic carcinoma, a relatively uncommon but devastating complication of many …
METHODS Details of the systematic literature review are provided in the full text of this guideline (https://www. cns. org/guidelines/guidelines-treatment-adults-metastatic-brain …
RS Prabhu, R Dhakal, ZK Vaslow, T Dan… - International Journal of …, 2021 - Elsevier
Purpose Preoperative radiosurgery (SRS) is a feasible alternative to postoperative SRS, with potential benefits in adverse radiation effect (ARE) and leptomeningeal disease (LMD) …
RS Prabhu, BE Turner, AL Asher, SR Marcrom… - Neuro …, 2019 - academic.oup.com
Background Radiographic leptomeningeal disease (LMD) develops in up to 30% of patients following postoperative stereotactic radiosurgery (SRS) for brain metastases. However, the …
MD Johnson, V Avkshtol, AM Baschnagel… - International Journal of …, 2016 - Elsevier
Purpose Recent prospective data have shown that patients with solitary or oligometastatic disease to the brain may be treated with upfront stereotactic radiosurgery (SRS) with deferral …
Importance Neurosurgical resection represents an important management strategy for patients with large, symptomatic brain metastases and increasingly is followed by …
KR Patel, SH Burri, D Boselli, JT Symanowski… - Journal of neuro …, 2017 - Springer
Pre-operative stereotactic radiosurgery (pre-SRS) has been shown as a viable treatment option for resectable brain metastases (BM). The aim of this study is to compare oncologic …